APO Research
Talk to an analyst

APO RESEARCH · REPORT

Companion Animal Postoperative Pain Management Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Companion Animal Postoperative Pain Management Therapeutics Market Analysis and Forecast 2026-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchCompanion Animal Postoperative Pain Management Therapeutics Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Companion Animal Postoperative Pain Management Therapeutics Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Companion Animal Postoperative Pain Management Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Companion Animal Postoperative Pain Management Therapeutics Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Companion Animal Postoperative Pain Management Therapeutics Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Companion Animal Postoperative Pain Management Therapeutics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Companion Animal Postoperative Pain Management Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Companion Animal Postoperative Pain Management Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Companion Animal Postoperative Pain Management Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Companion Animal Postoperative Pain Management Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Companion Animal Postoperative Pain Management Therapeutics include Zoetis, Merck Animal Health, Bayer AG, Norbrook, Elanco, Dechra Pharmaceuticals and Ceva Sante Animale, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Companion Animal Postoperative Pain Management Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Companion Animal Postoperative Pain Management Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Companion Animal Postoperative Pain Management Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Companion Animal Postoperative Pain Management Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Companion Animal Postoperative Pain Management Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Companion Animal Postoperative Pain Management Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Companion Animal Postoperative Pain Management Therapeutics Segment by Company

Zoetis

Merck Animal Health

Bayer AG

Norbrook

Elanco

Dechra Pharmaceuticals

Ceva Sante Animale

Companion Animal Postoperative Pain Management Therapeutics Segment by Type

Anesthetics

NSAIDs

Opioids

Others

Companion Animal Postoperative Pain Management Therapeutics Segment by Application

Canine

Feline

Companion Animal Postoperative Pain Management Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animal Postoperative Pain Management Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Companion Animal Postoperative Pain Management Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animal Postoperative Pain Management Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Companion Animal Postoperative Pain Management Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Companion Animal Postoperative Pain Management Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Companion Animal Postoperative Pain Management Therapeutics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Companion Animal Postoperative Pain Management Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Anesthetics Major Player Table 3. NSAIDs Major Player Table 4. Opioids Major Player Table 5. Others Major Player Table 6. Global Companion Animal Postoperative Pain Management Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Canine Major Player Table 8. Feline Major Player Table 9. Companion Animal Postoperative Pain Management Therapeutics Industry Trends Table 10. Companion Animal Postoperative Pain Management Therapeutics Industry Drivers Table 11. Companion Animal Postoperative Pain Management Therapeutics Industry Opportunities and Challenges Table 12. Companion Animal Postoperative Pain Management Therapeutics Industry Restraints Table 13. Global Companion Animal Postoperative Pain Management Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Companion Animal Postoperative Pain Management Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Companion Animal Postoperative Pain Management Therapeutics Market Share by Region (2021-2026) Table 16. Global Companion Animal Postoperative Pain Management Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Companion Animal Postoperative Pain Management Therapeutics Market Share by Region (2027-2032) Table 18. Global Companion Animal Postoperative Pain Management Therapeutics Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Companion Animal Postoperative Pain Management Therapeutics Revenue Market Share by Players (2021-2026) Table 20. Global Companion Animal Postoperative Pain Management Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Companion Animal Postoperative Pain Management Therapeutics Key Players Headquarters & Area Served Table 22. Global Companion Animal Postoperative Pain Management Therapeutics Players, Product Type & Application Table 23. Global Companion Animal Postoperative Pain Management Therapeutics Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Companion Animal Postoperative Pain Management Therapeutics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Companion Animal Postoperative Pain Management Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Companion Animal Postoperative Pain Management Therapeutics Revenue Market Share by Type (2021-2026) Table 30. Global Companion Animal Postoperative Pain Management Therapeutics Revenue Market Share by Type (2027-2032) Table 31. Global Companion Animal Postoperative Pain Management Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Companion Animal Postoperative Pain Management Therapeutics Revenue Market Share by Application (2021-2026) Table 35. Global Companion Animal Postoperative Pain Management Therapeutics Revenue Market Share by Application (2027-2032) Table 36. Zoetis Company Information Table 37. Zoetis Business Overview Table 38. Zoetis Companion Animal Postoperative Pain Management Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Zoetis Companion Animal Postoperative Pain Management Therapeutics Product Portfolio Table 40. Zoetis Recent Development Table 41. Merck Animal Health Company Information Table 42. Merck Animal Health Business Overview Table 43. Merck Animal Health Companion Animal Postoperative Pain Management Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Merck Animal Health Companion Animal Postoperative Pain Management Therapeutics Product Portfolio Table 45. Merck Animal Health Recent Development Table 46. Bayer AG Company Information Table 47. Bayer AG Business Overview Table 48. Bayer AG Companion Animal Postoperative Pain Management Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Bayer AG Companion Animal Postoperative Pain Management Therapeutics Product Portfolio Table 50. Bayer AG Recent Development Table 51. Norbrook Company Information Table 52. Norbrook Business Overview Table 53. Norbrook Companion Animal Postoperative Pain Management Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Norbrook Companion Animal Postoperative Pain Management Therapeutics Product Portfolio Table 55. Norbrook Recent Development Table 56. Elanco Company Information Table 57. Elanco Business Overview Table 58. Elanco Companion Animal Postoperative Pain Management Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Elanco Companion Animal Postoperative Pain Management Therapeutics Product Portfolio Table 60. Elanco Recent Development Table 61. Dechra Pharmaceuticals Company Information Table 62. Dechra Pharmaceuticals Business Overview Table 63. Dechra Pharmaceuticals Companion Animal Postoperative Pain Management Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Dechra Pharmaceuticals Companion Animal Postoperative Pain Management Therapeutics Product Portfolio Table 65. Dechra Pharmaceuticals Recent Development Table 66. Ceva Sante Animale Company Information Table 67. Ceva Sante Animale Business Overview Table 68. Ceva Sante Animale Companion Animal Postoperative Pain Management Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Ceva Sante Animale Companion Animal Postoperative Pain Management Therapeutics Product Portfolio Table 70. Ceva Sante Animale Recent Development Table 71. North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 72. North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 73. North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 74. North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 75. North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 77. North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 78. Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 79. Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 80. Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 81. Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 82. Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 83. Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 84. Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 85. China Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 86. China Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 87. China Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 88. China Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 89. Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 90. Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 91. Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 92. Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 93. Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Region (US$ Million) & (2021-2026) Table 95. Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Region (US$ Million) & (2027-2032) Table 96. SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 97. SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 98. SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 99. SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 100. SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 102. SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Companion Animal Postoperative Pain Management Therapeutics Image Figure 2. Global Companion Animal Postoperative Pain Management Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Companion Animal Postoperative Pain Management Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Anesthetics Image Figure 5. NSAIDs Image Figure 6. Opioids Image Figure 7. Others Image Figure 8. Global Companion Animal Postoperative Pain Management Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Companion Animal Postoperative Pain Management Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 10. Canine Image Figure 11. Feline Image Figure 12. Global Companion Animal Postoperative Pain Management Therapeutics Market Size (US$ Million) & (2021-2032) Figure 13. Global Companion Animal Postoperative Pain Management Therapeutics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Companion Animal Postoperative Pain Management Therapeutics Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Companion Animal Postoperative Pain Management Therapeutics Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Companion Animal Postoperative Pain Management Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Companion Animal Postoperative Pain Management Therapeutics Revenue Market Share by Type (2021-2032) Figure 20. Global Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Companion Animal Postoperative Pain Management Therapeutics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Companion Animal Postoperative Pain Management Therapeutics Revenue Market Share by Application (2021-2032) Figure 23. North America Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Type (2021-2032) Figure 25. North America Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Application (2021-2032) Figure 26. North America Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Country (2021-2032) Figure 27. United States Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Type (2021-2032) Figure 32. Europe Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Application (2021-2032) Figure 33. Europe Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Country (2021-2032) Figure 34. Germany Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Type (2021-2032) Figure 44. China Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Application (2021-2032) Figure 45. Asia Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Type (2021-2032) Figure 47. Asia Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Application (2021-2032) Figure 48. Asia Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Region (2021-2032) Figure 49. Japan Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Type (2021-2032) Figure 57. SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Application (2021-2032) Figure 58. SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Country (2021-2032) Figure 59. Brazil Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Companion Animal Postoperative Pain Management Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Anesthetics
  • NSAIDs
  • Opioids
  • Others
Applications
  • Canine
  • Feline
Companies covered
  • Zoetis
  • Merck Animal Health
  • Bayer AG
  • Norbrook
  • Elanco
  • Dechra Pharmaceuticals
  • Ceva Sante Animale

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Companion Animal Postoperative Pain Management Therapeutics Market by Type
  3. 1.2.1 Global Companion Animal Postoperative Pain Management Therapeutics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Anesthetics
  5. 1.2.3 NSAIDs
  6. 1.2.4 Opioids
  7. 1.2.5 Others
  8. 1.3 Companion Animal Postoperative Pain Management Therapeutics Market by Application
  9. 1.3.1 Global Companion Animal Postoperative Pain Management Therapeutics Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Canine
  11. 1.3.3 Feline
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Companion Animal Postoperative Pain Management Therapeutics Market Dynamics
  1. 2.1 Companion Animal Postoperative Pain Management Therapeutics Industry Trends
  2. 2.2 Companion Animal Postoperative Pain Management Therapeutics Industry Drivers
  3. 2.3 Companion Animal Postoperative Pain Management Therapeutics Industry Opportunities and Challenges
  4. 2.4 Companion Animal Postoperative Pain Management Therapeutics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Companion Animal Postoperative Pain Management Therapeutics Market Perspective (2021-2032)
  2. 3.2 Global Companion Animal Postoperative Pain Management Therapeutics Growth Trends by Region
  3. 3.2.1 Global Companion Animal Postoperative Pain Management Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Companion Animal Postoperative Pain Management Therapeutics Market Size by Region (2021-2026)
  5. 3.2.3 Global Companion Animal Postoperative Pain Management Therapeutics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Companion Animal Postoperative Pain Management Therapeutics Revenue by Players
  2. 4.1.1 Global Companion Animal Postoperative Pain Management Therapeutics Revenue by Players (2021-2026)
  3. 4.1.2 Global Companion Animal Postoperative Pain Management Therapeutics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Companion Animal Postoperative Pain Management Therapeutics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Companion Animal Postoperative Pain Management Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Companion Animal Postoperative Pain Management Therapeutics Key Players Headquarters & Area Served
  7. 4.4 Global Companion Animal Postoperative Pain Management Therapeutics Players, Product Type & Application
  8. 4.5 Global Companion Animal Postoperative Pain Management Therapeutics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Companion Animal Postoperative Pain Management Therapeutics Market CR5 and HHI
  11. 4.6.3 2025 Companion Animal Postoperative Pain Management Therapeutics Tier 1, Tier 2, and Tier 3
5 Companion Animal Postoperative Pain Management Therapeutics Market Size by Type
  1. 5.1 Global Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2032)
  3. 5.3 Global Companion Animal Postoperative Pain Management Therapeutics Revenue Market Share by Type (2021-2032)
6 Companion Animal Postoperative Pain Management Therapeutics Market Size by Application
  1. 6.1 Global Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2032)
  3. 6.3 Global Companion Animal Postoperative Pain Management Therapeutics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Zoetis
  2. 7.1.1 Zoetis Company Information
  3. 7.1.2 Zoetis Business Overview
  4. 7.1.3 Zoetis Companion Animal Postoperative Pain Management Therapeutics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Zoetis Companion Animal Postoperative Pain Management Therapeutics Product Portfolio
  6. 7.1.5 Zoetis Recent Developments
  7. 7.2 Merck Animal Health
  8. 7.2.1 Merck Animal Health Company Information
  9. 7.2.2 Merck Animal Health Business Overview
  10. 7.2.3 Merck Animal Health Companion Animal Postoperative Pain Management Therapeutics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Merck Animal Health Companion Animal Postoperative Pain Management Therapeutics Product Portfolio
  12. 7.2.5 Merck Animal Health Recent Developments
  13. 7.3 Bayer AG
  14. 7.3.1 Bayer AG Company Information
  15. 7.3.2 Bayer AG Business Overview
  16. 7.3.3 Bayer AG Companion Animal Postoperative Pain Management Therapeutics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bayer AG Companion Animal Postoperative Pain Management Therapeutics Product Portfolio
  18. 7.3.5 Bayer AG Recent Developments
  19. 7.4 Norbrook
  20. 7.4.1 Norbrook Company Information
  21. 7.4.2 Norbrook Business Overview
  22. 7.4.3 Norbrook Companion Animal Postoperative Pain Management Therapeutics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Norbrook Companion Animal Postoperative Pain Management Therapeutics Product Portfolio
  24. 7.4.5 Norbrook Recent Developments
  25. 7.5 Elanco
  26. 7.5.1 Elanco Company Information
  27. 7.5.2 Elanco Business Overview
  28. 7.5.3 Elanco Companion Animal Postoperative Pain Management Therapeutics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Elanco Companion Animal Postoperative Pain Management Therapeutics Product Portfolio
  30. 7.5.5 Elanco Recent Developments
  31. 7.6 Dechra Pharmaceuticals
  32. 7.6.1 Dechra Pharmaceuticals Company Information
  33. 7.6.2 Dechra Pharmaceuticals Business Overview
  34. 7.6.3 Dechra Pharmaceuticals Companion Animal Postoperative Pain Management Therapeutics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Dechra Pharmaceuticals Companion Animal Postoperative Pain Management Therapeutics Product Portfolio
  36. 7.6.5 Dechra Pharmaceuticals Recent Developments
  37. 7.7 Ceva Sante Animale
  38. 7.7.1 Ceva Sante Animale Company Information
  39. 7.7.2 Ceva Sante Animale Business Overview
  40. 7.7.3 Ceva Sante Animale Companion Animal Postoperative Pain Management Therapeutics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Ceva Sante Animale Companion Animal Postoperative Pain Management Therapeutics Product Portfolio
  42. 7.7.5 Ceva Sante Animale Recent Developments
8 North America
  1. 8.1 North America Companion Animal Postoperative Pain Management Therapeutics Revenue (2021-2032)
  2. 8.2 North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2032)
  3. 8.2.1 North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2026)
  4. 8.2.2 North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2027-2032)
  5. 8.3 North America Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Type (2021-2032)
  6. 8.4 North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2032)
  7. 8.4.1 North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2026)
  8. 8.4.2 North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2027-2032)
  9. 8.5 North America Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Application (2021-2032)
  10. 8.6 North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Country
  11. 8.6.1 North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2021-2026)
  13. 8.6.3 North America Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Companion Animal Postoperative Pain Management Therapeutics Revenue (2021-2032)
  2. 9.2 Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2027-2032)
  5. 9.3 Europe Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2027-2032)
  9. 9.5 Europe Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Country
  11. 9.6.1 Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Companion Animal Postoperative Pain Management Therapeutics Revenue (2021-2032)
  2. 10.2 China Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2032)
  3. 10.2.1 China Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2026)
  4. 10.2.2 China Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2027-2032)
  5. 10.3 China Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Type (2021-2032)
  6. 10.4 China Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2032)
  7. 10.4.1 China Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2026)
  8. 10.4.2 China Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2027-2032)
  9. 10.5 China Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Companion Animal Postoperative Pain Management Therapeutics Revenue (2021-2032)
  2. 11.2 Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2027-2032)
  5. 11.3 Asia Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2027-2032)
  9. 11.5 Asia Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Country
  11. 11.6.1 Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue (2021-2032)
  2. 12.2 SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Country
  11. 12.6.1 SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Companion Animal Postoperative Pain Management Therapeutics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst